Home > Boards > US OTC > Medical - Drugs > Creative Medical Technology Holdings, Inc. (CELZ)

If that quote was sourced from bioinformant.com they

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
justdafactss Member Profile
 
Followed By 11
Posts 4,025
Boards Moderated 1
Alias Born 09/12/17
160x600 placeholder
Information Statement (definitive, Revised) (defr14c) Edgar (US Regulatory) - 1/3/2020 4:02:13 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/13/2019 4:06:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/13/2019 4:05:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/13/2019 4:03:30 PM
Information Statement - All Other (definitive) (def 14c) Edgar (US Regulatory) - 11/22/2019 4:50:58 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2019 4:49:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/5/2019 6:40:49 PM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 11/5/2019 4:59:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/16/2019 4:03:28 PM
Information Statement - All Other (definitive) (def 14c) Edgar (US Regulatory) - 9/13/2019 4:46:21 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/9/2019 4:02:24 PM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 8/30/2019 4:02:45 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2019 4:49:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/31/2019 12:33:14 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/8/2019 4:02:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/3/2019 11:34:57 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/3/2019 11:32:16 AM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 6/28/2019 4:33:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/24/2019 2:24:35 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 6/20/2019 2:27:14 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/20/2019 4:48:52 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 5/15/2019 5:27:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/8/2019 6:44:37 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/2/2019 4:08:03 PM
Annual Report (10-k) Edgar (US Regulatory) - 4/1/2019 4:42:05 PM
justdafactss   Sunday, 10/20/19 08:18:09 PM
Re: uplinkjim post# 95237
Post # of 97416 
If that quote was sourced from bioinformant.com they are total liars---

BioInformant is the world’s first and only market research firm to specialize in the stem cell industry.
https://bioinformant.com/company/

Companies leading the charge in the area of exosome therapeutics include Anjarium Biosciences, Capricor Therapeutics, Codiak Biosciences, Creative Medical Technology Holdings, Everkine Corporation, Evox Therapeutics, Exogenus Therapeutics, Kimera Labs, ReNeuron, and Unicyte AG, a subsidiary of Fresenius Medical Care.
https://bioinformant.com/product/market-stem-cell-exosomes/

LMAO...Next---

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist